Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for CTD-ILD
NCT01424033Phase 3Terminated
- Sponsor
- University of Michigan
- Start
- Dec 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in interstitial lung disease (ILD), sponsored by University of Michigan. Started Dec 2011; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT01424033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01424033.